Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2006-09-05
2006-09-05
Gambel, Phillip (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S143100, C530S387100, C530S388220, C530S388230
Reexamination Certificate
active
07101550
ABSTRACT:
The invention identifies PD-1 as a receptor for B7-4. B7-4 can inhibit immune cell activation upon binding to an inhibitory receptor on an immune cell. Accordingly, the invention provides agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response.
REFERENCES:
patent: 5698520 (1997-12-01), Honjo et al.
patent: 6808710 (2004-10-01), Wood et al.
patent: 2002/0055139 (2002-05-01), Holtzman et al.
patent: WO 95/03408 (1995-02-01), None
Liang et al., Cur. Opin. Immunol. 2002; 14:384-390.
Greenwald et al., Cur. Opin. Immunol. 2002;14:391-396.
Agata, Yasutoshi et al., “Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.”International Immunology, (1996); vol. 8, No. 5, pp. 765-772.
Finger, Lawrence R. et al., “The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors.”Gene, (1997), vol. 197, pp. 177-187.
Freeman, Gordon, J. et al., “Engagement of the PD-1 Immunoinhibitory Recpetor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation.”The Journal of Experimental Medicine, (1998), vol. 192 No. 7, pp. 1027-1034.
Honjo, Tasuku, “Seppuku and Autoimmunity”Science, (1992), vol. 258, pp. 591-592.
Ishida, Yasumasa et al., “Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.”The EMBO Journal, (1992), vol. 11, No. 11, pp. 3887-3895.
Nishimura, Hiroyuki et al., “Developmental of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITM Motif-Carrying Immunoreceptor.”Immunity, (1999), vol. 11, pp. 141-151.
Nishimura, Hiroyuki et al., “Developmentally regulated expression of the PD-1 protein on the surface of double-negative (DC4‥CD8‥) thymocytes.”International Immunology, (1996), vol. 8, No. 5, pp. 773-780.
Nishimura, Hiroyuki et al., “Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses.”International Immunology, (1998), vol. 10, No. 10, pp. 1563-1572.
Nishimura, Hiroyuki et al., “PD-1 Regulates Self-Tolerance To Prevent Tissue Destruction.” (1998),Journal of Investigative Dermatology, vol. 110, No. 4, p. 477, abstract No. 25.
Nishimura, Hiroyuki et al., “PD-1 Regulates Self-Tolerance To Prevent Tissue Destruction.” (1998),Journal of Dermatological Science, vol. 16, Suppl. 1, p. S5, abstract No. 0025.
Nishimura, Hiroyuki et al., “Facilitation of β Selection and Modification of Positive Selection in the Thymus of PD-1-deficient Mice.”Journal of Experimental Medicine, (2000), vol. 191, No. 5, pp. 891-897.
Shinohara, Takashi et al., “Structure and Chromosomal Localization of the Human PD-1 Gene (PDCD1).”Genomics, (1994), vol. 23, pp. 704-706.
Vibhakar, Rajeev et al., “Activation-Induced Expression of Human Programmed Death-1 Gene in T-Lymphocytes.”Experimental Cell Research, (1997), vol. 232, pp. 25-28.
Vivier, Eric et al., “Immunoreceptor tyosin-based inhibition motifs.”Immunology Today, (1997), vol. 18, pp. 286-291.
Woronicz, J. et al., “Death Genes in T Cells.”Current Topics Microbiol. Immunol., (1995), vol. 200, pp. 137-146.
Dong, Haidong et al., “B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.”Nature Medicine, (1999), vol. 5, No. 12, pp. 1365-1369.
Henry, Joelle et al., “Structure and evolution of the extended B7 family.”Immunology Today, (1999), vol. 20, No. 6, pp. 285-288.
Genbank Acession No. AA292201 zt50f01.r1 Soares ovary tumor NbHOT Homo sapiens cDNA clone IMAGE:725785 5′, mRNA sequence, (1996).
Genbank Acession No. AA399416 zt50f01.s1 Soares ovary tumor NbHOT Homo sapiens cDNA clone IMAGE:725785 3′, mRNA sequence, (1996).
Genbank Acession No. AF177937 Homo sapiens B7-H1 mRNA, complete cds, (1999).
Genbank Acession No. Q13410 Butyrophilin precursor (BT), (1996).
Freeman Gordon J.
Wood Clive
Dana-Farber Cancer Institute Inc.
Foley & Hoag LLP
Gambel Phillip
Genetics Institute LLC
Ouspenski Ilia
LandOfFree
PD-1, a receptor for B7-4, and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PD-1, a receptor for B7-4, and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PD-1, a receptor for B7-4, and uses therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3574150